Respiratorius AB (FRA:HF00) Total Liabilities: €0.09 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:HF00 Respiratorius AB FRA:HF00
34 GF Score
Price €0.27
View Full Analysis

What is Respiratorius AB Total Liabilities?

Respiratorius AB FRA:HF00 34 Total Liabilities is €0.09 Mil as of Mar. 2026. GuruFocus rates FRA:HF00 with a GF Score™ of 34/100.

Respiratorius AB's Total Liabilities for the quarter that ended in Mar. 2026 was €0.09 Mil.

Respiratorius AB's quarterly Total Liabilities increased from Sep. 2025 (€0.08 Mil) to Dec. 2025 (€0.12 Mil) but then declined from Dec. 2025 (€0.12 Mil) to Mar. 2026 (€0.09 Mil).

Respiratorius AB's annual Total Liabilities declined from Dec. 2023 (€0.11 Mil) to Dec. 2024 (€0.08 Mil) but then increased from Dec. 2024 (€0.08 Mil) to Dec. 2025 (€0.12 Mil).


Respiratorius AB Total Liabilities Historical Data

* Premium members only.

The historical data trend for Respiratorius AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Respiratorius AB Total Liabilities Chart

Respiratorius AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 0.13 0.11 0.08 0.12

Respiratorius AB Quarterly Data
Mar21 Jun21 Sep21 Dec21 Apr22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.10 0.08 0.12 0.09
FRA:HF00
34GF Score
Respiratorius AB FRA:HF00
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Respiratorius AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Respiratorius AB's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=2.933-2.812
=0.12

Respiratorius AB's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=2.766-2.681
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €0.09 Mil mean?
Respiratorius AB (FRA:HF00) has a Total Liabilities of €0.09 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Respiratorius AB and its competitors.
Is Respiratorius AB's Total Liabilities too high?
Respiratorius AB's current Total Liabilities is €0.09 Mil. Overall, Respiratorius AB has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Respiratorius AB's Total Liabilities compare to VRTX and REGN?
Respiratorius AB's Total Liabilities of €0.09 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Respiratorius AB and its competitors. Respiratorius AB's current Total Liabilities is €0.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Respiratorius AB stock overvalued right now?
Respiratorius AB (FRA:HF00) has a current Total Liabilities of €0.09 Mil. The current Total Liabilities is €0.09 Mil. Respiratorius AB's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Respiratorius AB (FRA:HF00), the current Total Liabilities is €0.09 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Respiratorius AB Business Description

Other Exchanges RESP:Sweden
Address Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.
34GF Score

Get the complete analysis for FRA:HF00

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.27
Price